金吾财讯 | 阿波罗全球管理（APO）宣布，已与知名私募股权机构KKR（KKR）共同完成了对德国生命科学巨头拜耳（BAYRY）价值30亿欧元的资本解决方案交易。根据交易安排，阿波罗联合作为重要少数股权投资方加入的KKR，共同向一家新成立的实体注入股权资本。该实体持有拜耳的长效可逆避孕药（LARC）业务。交易完成后，拜耳仍保留该实体的控股权，并继续拥有完整的业务运营控制权，其原有的LARC战略将保持不变。阿波罗合伙人Jamshid Ehsani表示，此项定制化的数十亿欧元资本方案符合其“投资级资本解决方案”业务的发展方向。阿波罗同时重申，计划在未来十年内向德国市场投资超过1000亿美元，而与拜耳的合作正是其深耕德国核心企业战略的体现。本次交易中，Centerview Partners担任阿波罗基金的财务顾问。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.